STEPHANIE FERRARA: Open Payments
NPI 1790114965 · FORKED RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 29 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $235 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $140 |
| GlaxoSmithKline, LLC. | 5 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Exact Sciences Corporation | 3 | $50 |
| ABBVIE INC. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, Rybelsus, Wegovy, UBRELVY, XIFAXAN, FARXIGA, MOUNJARO, The Cologuard Plus Collection Kit.
Industry payments across NJ — which companies pay providers there.
